← Back to Insights
December 8, 2021
Authors
David Burda
Topics
Economics Outcomes Policy
Channels
Blogs

Why Prescription Drug Affordability Matters

It’s pretty safe to say that if I had taken better care of myself in my 30s, 40s and 50s, I wouldn’t be on four regular prescriptions medications at age 61. It’s seven at the moment if you add three short-term  prescription meds for a bad case of bronchitis as I write this. 

On the plus side, at the moment, I can afford my drugs, which I pray will help me get into my 70s, 80s and maybe even 90s. I’ve been steadily employed since age 23 and have always had health insurance coverage with pretty decent prescription drug benefits.  

I’m lucky. But millions of other adults aren’t.

A new report from the Urban Institute says that nearly 13 million adults didn’t get their prescriptions filled right away or at all in both 2018 and 2019—the last two years before the COVID-19 pandemic—because of the cost. You can download the 19-page report here

Researchers from the Urban Institute came up with that figure by analyzing 2018 and 2019 data from the Medical Expenditure Panel Survey, which the Agency for Healthcare Research and Quality administers each year. The researchers studied three primary sets of adults—those age 65 or older enrolled in Medicare; those age 19 to 64 with private health insurance for a full year; and those age 19 to 64 uninsured for all or part of a full year—who said they delayed or skipped filling one or more prescriptions in the previous 12 months because of the out-of-pocket cost.  

Here’s how the numbers broke down:

  • 4.1 million, or 32 percent, were nonelderly adults uninsured for all or part of a full year
  • 3.8 million, or 30 percent, were nonelderly adults with private health insurance for a full year
  • 2.3 million, or 18 percent, were Medicare-only enrollees with drug coverage for a full year
  • The balance—2.5 million, or 20 percent—were nonelderly adults with Medicaid coverage or coverage from another source and dual eligible Medicare beneficiaries with Medicaid coverage

What’s interesting about what the researchers found is the fact that nearly half—48 percent—of those who said they delayed or skipped filling a prescription because of the cost had health insurance for a full year either through Medicare or through a commercial health plan. In-other-words, they couldn’t afford their out-of-pocket deductibles, coinsurance and copayments for their medications even with insurance.

And it didn’t take much in terms of dollars for them to delay or skip a prescription. For 44 percent of the Medicare beneficiaries, it was as little as $500 a year. Same for 21 percent of the nonelderly adults.

“Though most adults with Medicare or private coverage had modest out-of-pocket costs for prescription drugs, some experienced high spending burdens relative to their incomes, which could further exacerbate unmet needs for other types of care,” the researchers said.

And for what medical conditions did these folks delay or skip their meds?

For Medicare beneficiaries, the top five conditions were:

  • Joint pain, including arthritis
  • High blood pressure
  • High cholesterol
  • Heart disease
  • Diabetes

For the nonelderly, they were:

  • Joint pain, including arthritis
  • High blood pressure
  • High cholesterol
  • Asthma
  • Diabetes

Undoubtedly and unfortunately, a lot of these people will wind up going to urgent care or the hospital emergency room when their chronic conditions escalate into acute problems. All because they couldn’t afford to fill their prescriptions. 

I’m no actuary, but wouldn’t it be fiscally smarter to design benefits plans that make prescription drugs as cheap as possible for patients and incentivize medication adherence so you, as a health plan or payer,   avoid writing big checks to hospitals and medical specialists later? Makes sense to me.  That’s a market-based solution that doesn’t require any government intervention. 

To learn more about this topic, please read “Maybe It’s the Patients, Not the Prices. Is that Stupid? on 4sighthealth.com

Thanks for reading.

About the Authors

David Burda

Dave is 4sight Health’s biggest news junkie, resident journalist and healthcare historian. He began covering healthcare in 1983 and hasn’t stopped since. Dave writes his own column, “Burda on Health,” for us, contributes weekly blog posts, and manages our weekly e-newsletter and weekly podcast, 4sight Friday and 4sight Roundup.

Dave believes that healthcare is a business like any other business, and customers—patients—are king. If you do what’s right for patients, good business results will follow.

Dave’s personal experiences with the healthcare system both as a patient and family caregiver have shaped his point of view. It’s also been shaped by covering the industry for 35 years as a reporter and editor. He worked at Modern Healthcare for 25 years, the last 11 as editor.

Prior to Modern Healthcare, he did stints at the American Medical Record Association (now AHIMA) and the American Hospital Association. After Modern Healthcare, he wrote a monthly column for Twin Cities Business explaining healthcare trends to a business audience, and he developed and executed content marketing plans for leading healthcare corporations as the editorial director for healthcare strategies at MSP Communications.

When he’s not reading and writing about healthcare, Dave spends his time riding the trails of DuPage County, IL, on his bike, tending his vegetable garden and daydreaming about being a lobster fisherman in Maine. He lives in Wheaton, IL, with his lovely wife of 35 years and his three children, none of whom want to be journalists or lobster fishermen.

Recent Posts

Economics
Podcast: 4sight Friday Roundup, Digital Health Wheeling and Dealing, 1/14/21
Digital Health Wheeling and Dealing Digital health technology funding is through the roof along with digital health M&A… Read More
By January 14, 2022
Economics
Adding Up the Romantic and Philosophical Benefits of Provider Affiliations
In Bargain, Pete Townshend of The Who sings, “One and one don’t make two. One and one make… Read More
By January 12, 2022
Default Image
Economics
4sight Friday | 2022 Healthcare Predictions | Is VBR Mostly Dead or Slightly Alive?
Read 1/7/2022 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More
By January 7, 2022